RT Journal Article
SR Electronic
T1 Risks and benefits of combining immunosuppressives and biological agents in inflammatory bowel disease: is the synergy worth the risk?
JF Gut
JO Gut
FD BMJ Publishing Group Ltd and British Society of Gastroenterology
SP 1181
OP 1183
DO 10.1136/gut.2006.115980
VO 56
IS 9
A1 Hanauer, Stephen B
YR 2007
UL http://gut.bmj.com/content/56/9/1181.abstract
AB